title: Alanyl-glutamine dipeptide does not affect hemodynamics despite a greater increase in myocardial heat shock protein 72 immunoreactivity in endotoxemic sheep.
abstract: The possible beneficial effect of supplemental glutamine (Gln) in critically ill patients has been suggested to be mediated by the induction of the cytoprotective heat shock proteins (HSP)32 and HSP72. There is evidence that HSP72 and HSP32 have opposite effects on the hemodynamic situation during endotoxemia. Therefore, the effect of Gln supplementation on the cardiovascular system is not clear. We investigated the effect of alanyl-Gln (Ala-Gln) dipeptide on cardiovascular function in healthy and endotoxemic sheep. Ten sheep catheterized for chronic studies received Ala-Gln 700 mg/(kg x d) [equal to 470 mg/(kg x d)Gln] on 4 consecutive days, and 10 sheep received NaCl (9 g/L) as the control solution. On d 4, four sheep of each group were killed and myocardial samples were taken for immunohistochemistry. The remaining sheep received a continuous infusion of endotoxin [Salmonella typhosa, 10 ng/(kg x min)]. Hemodynamic parameters were measured before application of Ala-Gln or the control solution, and during endotoxemia. Myocardial HSP72 immunoreactivity was determined by immunohistochemistry. After 24 h of endotoxemia, the sheep exhibited a hyperdynamic circulation. No difference was found in the hemodynamic parameters between treatment and control group. Ala-Gln treated sheep had a greater increase in myocardial HSP72 immunoreactivity compared with controls after (P < 0.05) but not before endotoxemia. In summary, Ala-Gln increased HSP72 immunoreactivity after endotoxemia, but did not alter hemodynamic parameters. Thus, Ala-Gln supplementation does not seem to aggravate the hyperdynamic circulation in endotoxemic shock.
authors.affiliation: Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Gerhard-Domagk-Institut für Pathologie, Westfälische Wilhelms-Universität Münster, Germany. schartm@uni-muenstar.de
authors.forename: M
authors.initials: M
authors.lastname: Scharte
authors.forename: H A
authors.initials: HA
authors.lastname: Baba
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
authors.forename: C
authors.initials: C
authors.lastname: Schulzki
authors.forename: J
authors.initials: J
authors.lastname: Meyer
authors.forename: C
authors.initials: C
authors.lastname: Goeters
authors.forename: H G
authors.initials: HG
authors.lastname: Bone
mesh_terms: D000818:Animals; D004151:Dipeptides / Q000627:therapeutic use*; D019446:Endotoxemia / Q000188:drug therapy*; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins / Q000378:metabolism*; D006439:Hemodynamics / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism*; D012756:Sheep; D014435:Typhoid Fever / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D004151:Dipeptides; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins; C054122:alanylglutamine